Brief: Biocept To Collaborate With Quest Diagnostics To Provide Advanced Ngs-Based Liquid Biopsy Testing For Patients With Lung Cancer
22/06/2021 13:38
June 22 (Reuters) - Biocept Inc BIOC.O :
* BIOCEPT TO COLLABORATE WITH QUEST DIAGNOSTICS TO PROVIDE
ADVANCED NGS-BASED LIQUID BIOPSY TESTING FOR PATIENTS WITH LUNG
CANCER
* BIOCEPT INC - TWO PARTIES EXPECT SERVICE TO BE AVAILABLE
TO
QUEST DIAGNOSTICS' PROVIDERS AND PATIENTS IN Q4 OF 2021
Source text for Eikon: ID:nBw6tt0R3a
Further company coverage: BIOC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biocept
See all newsBrief: Biocept Says Trading Of Common Stock Will Be Suspended By Nasdaq At Opening Of Business On Oct 25
U.S. STOCKS ON THE MOVE-Overstock.com, Biocept, Birkenstock
Biocept slumps after filing for bankruptcy protection
Brief: Biocept CEO Antonino Morales Resigns
U.S. STOCKS ON THE MOVE-Albemarle, Novavax, WeWork